Diabetes Clinical Trials in Miami

Showing 121-140 of 388 trials

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

NCT03531905

12 week study to assess the LDL-C lowering efficacy, other lipid and glycemic measures, and safety of bempedoic acid/ezetimibe FDC compared to ezetimibe and placebo in patients with type 2 diabetes (T2D) and elevated LDL-C

DiabetesDiabetes Mellitus, Type 2Cholesterolemia

Esperion Therapeutics, Inc.242 participantsStarted May 2018

Lincoln, California, United States • Miami, Florida, United States • Louisville, Kentucky, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

NCT02459899

The primary objective of this study was to define the dose leading to desirable efficacy, as measured by the change in hemoglobin A1C (A1C) between Baseline and Week 12.

Type 1 Diabetes Mellitus

Lexicon Pharmaceuticals141 participantsStarted Jul 2015

Concord, California, United States • Ventura, California, United States • Denver, Colorado, United States +14 more locations

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Diabetes Trials in Other Cities

Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Patient and Provider Assessment of Lipid Management Registry

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

Other Conditions in Miami